title: Suxamethonium induced prolonged apnea in a patient receiving electroconvulsive therapy.
abstract: Suxamethonium causes prolonged apnea in patients in whom pseudocholinesterase enzyme gets deactivated by organophosphorus (OP) poisons. Here, we present a similar incident in a severely depressed patient who received electroconvulsive therapy (ECT). Prolonged apnea in our case ensued because the information about suicidal attempt by OP compound was concealed from the treating team.
authors.affiliation: Department of Psychiatry, National Institute of Mental Health and Neurosciences, Bangalore 560002, India.
authors.forename: Avinash
authors.initials: A
authors.lastname: Waghmare
authors.forename: Channaveerachari Naveen
authors.initials: CN
authors.lastname: Kumar
authors.forename: Jagadisha
authors.initials: J
authors.lastname: Thirthalli
mesh_terms: D000328:Adult; D001049:Apnea / Q000139:chemically induced*; D002389:Catatonia / Q000628:therapy; D003865:Major Depressive Disorder / Q000628:therapy; D004347:Drug Interactions; D004565:Electroconvulsive Therapy / Q000009:adverse effects*; D006801:Humans; D008297:Male; D009467:Neuromuscular Depolarizing Agents / Q000009:adverse effects*; D062025:Organophosphate Poisoning; D013390:Succinylcholine / Q000009:adverse effects*; D013406:Suicide, Attempted
chemical_list: D009467:Neuromuscular Depolarizing Agents; D013390:Succinylcholine